Showing results (91-100 of 840) with videos related to
Sort By:
Pageof 84
Hepatology (Baltimore, Md.)|January 29, 2011
Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cellsHongwei He, Albert Mennone, James L Boyer, et al.American Journal of Physiology. Cell Physiology|November 12, 2016
CFTR-associated ligand is a negative regulator of Mrp2 expressionMan Li, Carol J Soroka, Kathy Harry, et al.Hepatology (Baltimore, Md.)|December 14, 2011
A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosisPing Lam, Shuhua Xu, Carol J Soroka, et al.ESMO Open|November 16, 2016
Cancer and liver cirrhosis: implications on prognosis and managementMatthias Pinter, Michael Trauner, Markus Peck-Radosavljevic, et al.Hepatology (Baltimore, Md.)|December 21, 2016
New therapeutic concepts in bile acid transport and signaling for management of cholestasisMichael Trauner, Claudia Daniela Fuchs, Emina Halilbasic, et al.International Journal of Molecular Sciences|August 6, 2014
Cystic fibrosis related liver disease--another black box in hepatologyKatharina Staufer, Emina Halilbasic, Michael Trauner, et al.Nature Reviews. Gastroenterology & Hepatology|August 29, 2013
Bile acid receptors as targets for drug developmentFrank G Schaap, Michael Trauner, Peter L M JansenBMJ Case Reports|January 29, 2016
Difficult case of Cronkhite-Canada syndrome with small intestinal bacterial overgrowth, Clostridium difficile infection and polymyalgia rheumaticaStefan Traussnigg, Werner Dolak, Michael Trauner, et al.Clinical and Experimental Rheumatology|September 3, 2016
Bile acids in regulation of inflammation and immunity: friend or foe?Ci Zhu, Claudia D Fuchs, Emina Halilbasic, et al.Molecular Pharmaceutics|June 6, 2006
Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerationsGernot Zollner, Hanns-Ulrich Marschall, Martin Wagner, et al.Pageof 84